Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues.

Chang KC, Laffin B, Ponder J, Enzsöly A, Németh J, LaBarbera DV, Petrash JM.

Chem Biol Interact. 2013 Feb 25;202(1-3):283-7. doi: 10.1016/j.cbi.2012.12.001. Epub 2012 Dec 15.

2.

Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages.

Ramana KV, Fadl AA, Tammali R, Reddy AB, Chopra AK, Srivastava SK.

J Biol Chem. 2006 Nov 3;281(44):33019-29. Epub 2006 Sep 6.

3.

Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells.

Chang KC, Snow A, LaBarbera DV, Petrash JM.

Chem Biol Interact. 2015 Jun 5;234:254-60. doi: 10.1016/j.cbi.2014.10.007. Epub 2014 Oct 18.

4.

Aldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophages.

Ramana KV, Reddy AB, Tammali R, Srivastava SK.

Free Radic Biol Med. 2007 Apr 15;42(8):1290-302. Epub 2007 Jan 24.

5.

Inhibition of aldose reductase prevents endotoxin-induced inflammation by regulating the arachidonic acid pathway in murine macrophages.

Shoeb M, Yadav UC, Srivastava SK, Ramana KV.

Free Radic Biol Med. 2011 Nov 1;51(9):1686-96. doi: 10.1016/j.freeradbiomed.2011.07.024. Epub 2011 Aug 5.

6.

Aldose reductase inhibition prevents lipopolysaccharide-induced glucose uptake and glucose transporter 3 expression in RAW264.7 macrophages.

Reddy AB, Srivastava SK, Ramana KV.

Int J Biochem Cell Biol. 2010 Jun;42(6):1039-45. doi: 10.1016/j.biocel.2010.03.014. Epub 2010 Mar 27.

7.

The isolation and characterization of β-glucogallin as a novel aldose reductase inhibitor from Emblica officinalis.

Puppala M, Ponder J, Suryanarayana P, Reddy GB, Petrash JM, LaBarbera DV.

PLoS One. 2012;7(4):e31399. doi: 10.1371/journal.pone.0031399. Epub 2012 Apr 2.

8.

Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat.

Takahashi K, Mizukami H, Kamata K, Inaba W, Kato N, Hibi C, Yagihashi S.

PLoS One. 2012;7(1):e30134. doi: 10.1371/journal.pone.0030134. Epub 2012 Jan 12.

9.

Aldose reductase prevents aldehyde toxicity in cultured human lens epithelial cells.

Pladzyk A, Ramana KV, Ansari NH, Srivastava SK.

Exp Eye Res. 2006 Aug;83(2):408-16. Epub 2006 Apr 24.

PMID:
16631166
10.

Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells.

Pladzyk A, Reddy AB, Yadav UC, Tammali R, Ramana KV, Srivastava SK.

Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5395-403.

PMID:
17122129
11.
12.

Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia.

Chang KC, Ponder J, Labarbera DV, Petrash JM.

Invest Ophthalmol Vis Sci. 2014 May 2;55(5):2853-61. doi: 10.1167/iovs.13-13487.

13.

AMPK activation inhibits expression of proinflammatory mediators through downregulation of PI3K/p38 MAPK and NF-κB signaling in murine macrophages.

Huang BP, Lin CH, Chen HM, Lin JT, Cheng YF, Kao SH.

DNA Cell Biol. 2015 Feb;34(2):133-41. doi: 10.1089/dna.2014.2630. Epub 2014 Dec 23.

PMID:
25536376
14.

Inhibition of ocular aldose reductase by a new benzofuroxane derivative ameliorates rat endotoxic uveitis.

Di Filippo C, Zippo MV, Maisto R, Trotta MC, Siniscalco D, Ferraro B, Ferraraccio F, La Motta C, Sartini S, Cosconati S, Novellino E, Gesualdo C, Simonelli F, Rossi S, D'Amico M.

Mediators Inflamm. 2014;2014:857958. doi: 10.1155/2014/857958. Epub 2014 Nov 11.

15.

A novel chromone derivative with anti-inflammatory property via inhibition of ROS-dependent activation of TRAF6-ASK1-p38 pathway.

Liu H, Xu R, Feng L, Guo W, Cao N, Qian C, Teng P, Wang L, Wu X, Sun Y, Li J, Shen Y, Xu Q.

PLoS One. 2012;7(8):e37168. doi: 10.1371/journal.pone.0037168. Epub 2012 Jun 15.

18.

Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation.

Brando Lima AC, Machado AL, Simon P, Cavalcante MM, Rezende DC, Sperandio da Silva GM, Nascimento PG, Quintas LE, Cunha FQ, Barreiro EJ, Lima LM, Koatz VL.

Pharmacol Rep. 2011;63(4):1029-39.

19.

Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells.

Kobori M, Yoshida M, Ohnishi-Kameyama M, Shinmoto H.

Br J Pharmacol. 2007 Jan;150(2):209-19. Epub 2006 Dec 11.

Supplemental Content

Support Center